Investigating the performance of a novel pH and cathepsin B sensitive, stimulus-responsive nanoparticle for optimised sonodynamic therapy in prostate cancer. (2021)
Attributed to:
A novel tumour-responsive formulation for delivering sonodynamic treatment of prostate cancer
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.jconrel.2020.11.040
PubMed Identifier: 33245955
Publication URI: http://europepmc.org/abstract/MED/33245955
Type: Journal Article/Review
Volume: 329
Parent Publication: Journal of controlled release : official journal of the Controlled Release Society
ISSN: 0168-3659